TN
Therapeutic Areas
Mitera Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Placental Protein Program | Autoimmune disorders & Solid organ transplant rejection | Preclinical |
Leadership Team at Mitera Biosciences
KC
Kevin Chow, PhD
Co-founder, President & CEO
SC
Stanley C. Jordan, MD
Co-founder & Chief Scientific Officer
SA
S. Ananth Karumanchi, MD
Co-founder & Lead Scientific Advisor
KM
Kristin Mulready, MS, GCEC
Head of Program Management
SR
Scott Rudge, PhD
Head of CMC
AK
Amanda Kohler, PhD
Head of Protein Engineering